Apex Biotechnology Corp. (TPE:1733)
32.00
-0.05 (-0.16%)
Apr 29, 2025, 1:35 PM CST
Apex Biotechnology Company Description
Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide.
The company offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing, and hemosmart gold hemoglobin screening systems.
It also provides pesticide residue check systems; and care management and tele-health services. The company was incorporated in 1997 and is headquartered in Hsinchu City, Taiwan.
Apex Biotechnology Corp.
Country | Taiwan |
Founded | 1997 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Yanshi Shen |
Contact Details
Address: No. 7, Li-Hsin 5th Road Hsinchu City, 30078 Taiwan | |
Phone | 886 3 564 1952 |
Website | apexbio.com |
Stock Details
Ticker Symbol | 1733 |
Exchange | Taiwan Stock Exchange |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | TWD |
ISIN Number | TW0001733004 |
SIC Code | 2835 |
Key Executives
Name | Position |
---|---|
Dr. Yanshi Shen Ph.D. | Chairman, Chief Executive Officer and GM |
Yingxiang Chu | Chief Financial Officer |
Chun Hui Wu | Vice President of Administration and Spokesman |
Yanshi Shen | Vice President of Marketing and Sales |
Meng Wen Yang | Vice GM, Vice President of Manufacturing and Director |